These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1924930)
1. [The evaluation in primary care of blood theophylline in patients with chronic obstructive pulmonary disease]. Isanta Pomar C; Subías Lorén P; Baquer Masgrau A; Auría Romeo C; Martín Moros JM; Izquierdo Clemente C Rev Clin Esp; 1991 Jun; 189(1):42-3. PubMed ID: 1924930 [No Abstract] [Full Text] [Related]
2. [Determination of the serum level of theophylline in a group of patients with chronic obstructive bronchopneumopathy]. Marzo C; Gnasso P; Dericoloso A; Borrelli G; Vacca C; Cantone F Arch Monaldi; 1981; 36(1-2):71-5. PubMed ID: 7348162 [No Abstract] [Full Text] [Related]
3. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease. Fontana G; Cresci F; Lo Sapio P; Panuccio P Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008 [TBL] [Abstract][Full Text] [Related]
4. [Levels of blood theophylline in patients with acute bronchospasm]. Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324 [TBL] [Abstract][Full Text] [Related]
5. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease]. Harder S; Staib AH; Stauder J Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931 [No Abstract] [Full Text] [Related]
6. [Norfloxacin does not raise theophylline concentrations in plasma]. Tamura G; Satoh K; Ohtsu H; Fujimoto Y; Aizawa T; Sakai K; Mue S; Takishima T Arerugi; 1987 May; 36(5):262-7. PubMed ID: 3662833 [No Abstract] [Full Text] [Related]
7. Theophylline binding to plasma proteins in patients with chronic obstructive pulmonary disease. Calandre EP; Pérez de la Cruz A; Alferez NP; Moreno Carretero E; Hinojosa R; Vázquez Mata G Int J Clin Pharmacol Res; 1986; 6(5):397-401. PubMed ID: 3781702 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction. Grassi V; Nicora M; Beretta A Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006 [TBL] [Abstract][Full Text] [Related]
9. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo]. Aamodt T; Lien JT; Haaversen O; Osmundsen K Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660 [No Abstract] [Full Text] [Related]
10. [Interactions of theophylline and nifedipine]. Luther R; Wichert H; Köhler E; Banditt P; Walther H Z Erkr Atmungsorgane; 1990; 174(2):97-103. PubMed ID: 2349818 [TBL] [Abstract][Full Text] [Related]
11. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations]. Ranke C; Schmidt G; Oellerich M; Sybrecht GW Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564 [No Abstract] [Full Text] [Related]
12. [Serum theophylline levels in chronic obstructive pulmonary disease patients receiving uniphyllin]. Chang SC; Perng RP Zhonghua Yi Xue Za Zhi (Taipei); 1988 Jan; 41(1):37-42. PubMed ID: 3167647 [No Abstract] [Full Text] [Related]
13. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form]. Kaik G Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156 [TBL] [Abstract][Full Text] [Related]
14. [Long-term therapy with a retard theophylline preparation]. Keller A; Bömches B; Kandt D Fortschr Med; 1995 May; 113(13):197-202. PubMed ID: 7782018 [TBL] [Abstract][Full Text] [Related]
15. [Plasma concentrations of theophylline in patients with chronic obstructive pulmonary disease. What therapeutic limit should be used?]. Soto J; Sacristán JA Med Clin (Barc); 1992 Mar; 98(10):398-9. PubMed ID: 1564977 [No Abstract] [Full Text] [Related]
16. [Serum theophylline concentrations in patients with chronic obstructive lung diseases: a comparison of 2 methods]. Voshaar T; Schweisfurth H; Schöttes C; Prinsen J; Koch HP Pneumologie; 1990 Feb; 44 Suppl 1():283-4. PubMed ID: 2195516 [TBL] [Abstract][Full Text] [Related]
17. Home monitoring of theophylline levels: a novel therapeutic approach. Chandler MH; Clifton GD; Louis BA; Coons SJ; Foster TS; Phillips BA Pharmacotherapy; 1990; 10(4):294-300. PubMed ID: 2388876 [TBL] [Abstract][Full Text] [Related]
18. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases]. Salikova VV; Nonikov VE; Belousov IuB Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801 [TBL] [Abstract][Full Text] [Related]
19. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation. Dal Negro R; Turco P; Pomari C; Monici-Preti P Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):401-5. PubMed ID: 3305382 [TBL] [Abstract][Full Text] [Related]